ArticleOphthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)2026
Evaluation of Factors Influencing Quality of Life in Keratoconus Patients Using the Keratoconus Outcomes Research Questionnaire (KORQ).
Article in Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reduced Image Quality Impairs Monocular Blur-Driven Accommodation in Keratoconus.Investigative ophthalmology & visual science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess quality of life (QoL) in patients with keratoconus using the Keratoconus Outcomes Research Questionnaire (KORQ) and to investigate the influence of clinical and demographic variables on questionnaire scores.
methodsPatients with a diagnosis of bilateral keratoconus presenting at the cornea service self-completed the KORQ questionnaire. To investigate factors influencing QoL, associations between KORQ scores and sex, age, optical correction, history of corneal cross-linking, best corrected visual acuity, steepest keratometry, central corneal thickness, Amsler-Krumeich stage, posterior symmetry index, higher-order aberrations and coma were assessed using univariate and multivariable linear regression analysis.
resultsIn total, 153 patients were included. Both the Activity Limitation and the Symptoms subscale scores of the KORQ were inversely correlated with keratometric and aberrometric readings and disease stage of both eyes. Also, the 'driving at night' and 'seeing in poor light' functional domains were negatively affected by aberrometric readings. In the multivariable regression model, sex, use of correction, use of rigid-gas-permeable contact lenses, higher-order aberration and posterior symmetry index were retained as significant independent predictors for functional score, explaining 25.5% of the variance (adjusted R² = 21.3%, p < 0.001). For the symptoms score, sex, keratoconus stage and posterior symmetry index were retained as significant independent predictors, explaining 14.7% of the variance (adjusted R² = 11.2%, p < 0.001). Gender-stratified regression models highlighted sex-specific differences in predictors.
conclusionsIn patients with keratoconus, higher disease stage and higher values of keratometric and aberrometric readings negatively affected both functional and symptom scores on the KORQ. Male sex, lower posterior symmetry index, lower keratoconus stage and lower higher-order aberrations were the strongest independent predictors of better QoL. The posterior symmetry index emerged as a novel determinant of QoL, translating early structural changes into a meaningful impact on patients' visual functioning.
Indexed as
Identifiers
41893994What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.